Home » Topics » BioWorld Science

BioWorld Science
RSS

Company Profile: Athena Neurosciences

Dec. 10, 1997

Propecia recommended for approval for hair loss in men

Dec. 9, 1997

FDA advisory committee recommends approval of TOBI

Dec. 9, 1997

Boehringer Mannheim returns to PDL rights to two antiviral compounds

Dec. 9, 1997

StressGen prepares to evaluate Oncocine in clinical trials

Dec. 9, 1997

FDA approves shorter treatment claim for Mentax

Dec. 9, 1997

Preclinical toxicity profile of ISIS-2503

Dec. 9, 1997

BioTime reports preliminary phase III data from Hextend trial

Dec. 9, 1997

Novel liver-targeted conjugate for hepatitis B virus infection

Dec. 9, 1997

Adefovir dipivoxil now available in expanded access program

Dec. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...